Suven Life Sciences takes part at 4th CNS Partnering & Deal Making Conference

22 Sep 2011 Evaluate

Suven Life Sciences, a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, is participating at 4 CNS Partnering & Deal making Conference held at San Francisco, USA from 22nd to 23rd September 2011.

The CEO of the company is scheduled to discuss the company's corporate overview, business strategy and partnering activity by presenting their Phase 2 ready clinical candidate SUVN-502 for cognition in Alzheimer's and Schizophrenia and other pipeline compounds at this Partnering & Deal making conference where the world’s top notch investment professionals will present along with the most innovative companies who are decision makers.

CNS Partnering & Deal Making Conference is a CNS Diseases partnering a business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry. This event also provides a unique venue for attendees to learn about CNS Diseases business development trends, the CNS disease market, and novel technologies that shape up the industry.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets. The Company has twelve internally-discovered therapeutic drug candidates currently in pre-clinical stage of development targeting conditions such as ADHD, Dementia, Depression, Huntington’s disease, Parkinson’s disease and obesity in addition to developmental candidate SUVN-502 for Alzheimer’s disease and Schizophrenia.

Suven Life Sciences Share Price

122.40 2.85 (2.38%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...